moderna mrna - Search News

News

Moderna, influenza vaccine and mRNA-1010

The Wall Street Journal on MSN · 23h

Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Moderna’s Promised mRNA Flu Vaccine Bests Current Standard Shot

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the company pulled its application for a combo flu/COVID-19 shot, saying it would refile following data from this Phase III trial.

Detroit Free Press · 22h

Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older CAMBRIDGE,

The Silicon Review40m

Moderna flu shot outperforms marketed vaccines in pivotal late-stage trial

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...

STAT1dOpinion

The U.S. must invest in mRNA vaccines against pandemic influenza viruses now

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results